De novo use of a generic formulation of tacrolimus versus reference tacrolimus in kidney transplantation: evaluation of the clinical results, histology in protocol biopsies, and immunological monitoring

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 11, 2015-11 ,pp. : 1283-1290

John Wiley & Sons Inc

Access to resources Recommend Favorite

HISTOLOGICAL FINDINGS IN PROTOCOL BIOPSIES FOLLOWING PAEDIATRIC LIVER TRANSPLANTATION: LOW INCIDENCE OF ABNORMALITIES WITH PREDOMINANTLY TACROLIMUS MONOTHERAPY AT FIVE YEARS

By  

JOURNAL OF PAEDIATRICS AND CHILD HEALTH, Vol. 51, Iss. S2, 2015-05 ,pp. : 12-13

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Prospective Randomised Paired Trial of Sirolimus versus Tacrolimus as Primary Immunosuppression following Non-Heart Beating Donor Kidney Transplantation

By  

Current Urology, Vol. 7, Iss. 4, 2014-08 ,pp. : 174-180

Karger

Access to resources Recommend Favorite

Comparison of tacrolimus and cyclosporin A in CYP3A5 expressing Chinese de novo kidney transplant recipients: a 2‐year prospective study

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. S183, 2015-05 ,pp. : 43-52

John Wiley & Sons Inc

Access to resources Recommend Favorite

Severe Neurotoxicity in Tacrolimus-Treated Living Kidney Transplantation in Two Cases

By  

Urologia Internationalis, Vol. 71, Iss. 4, 2003-11 ,pp. : 433-434

Karger

Access to resources Recommend Favorite